[HTML][HTML] Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
Background: Owing to late diagnosis in advanced disease stages, prognosis of patients with
epithelial ovarian cancer (EOC) is poor. The quantification of deregulated levels of …
epithelial ovarian cancer (EOC) is poor. The quantification of deregulated levels of …
[HTML][HTML] Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
SF Chen, Z Liu, S Chaurasiya, TH Dellinger, J Lu… - Oncotarget, 2018 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) have recently demonstrated great potential and enormous promise in
the diagnosis, prognosis and therapy of various types of cancer. In this study, we performed …
the diagnosis, prognosis and therapy of various types of cancer. In this study, we performed …
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
R Eitan, M Kushnir, G Lithwick-Yanai, MB David… - Gynecologic …, 2009 - Elsevier
BACKGROUND: Ovarian cancer, the leading cause of gynecologic cancer deaths, is usually
diagnosed in advanced stages. Prognosis relates to stage at diagnosis and sensitivity to …
diagnosed in advanced stages. Prognosis relates to stage at diagnosis and sensitivity to …
[HTML][HTML] MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications
M Yanokura, K Banno, Y Kobayashi… - Oncology …, 2010 - spandidos-publications.com
MicroRNAs (miRNAs) are small non-coding RNAs of approximately 22 base pairs that
regulate the expression of genes by targeting messenger RNA with complementarity with …
regulate the expression of genes by targeting messenger RNA with complementarity with …
Current status on micro RNA s as biomarkers for ovarian cancer
KP Prahm, GW Novotny, C Høgdall, E Høgdall - Apmis, 2016 - Wiley Online Library
Ovarian cancer (OC) is the most lethal gynecological malignancy in the W estern world, and
has a very poor prognosis, often due to late diagnosis and emergence of chemotherapy …
has a very poor prognosis, often due to late diagnosis and emergence of chemotherapy …
[HTML][HTML] Identifying microRNA/mRNA dysregulations in ovarian cancer
Background MicroRNAs are a class of noncoding RNA molecules that co-regulate the
expression of multiple genes via mRNA transcript degradation or translation inhibition. Since …
expression of multiple genes via mRNA transcript degradation or translation inhibition. Since …
[HTML][HTML] MicroRNA characteristics in epithelial ovarian cancer
KP Prahm, CK Høgdall, MA Karlsen, IJ Christensen… - Plos one, 2021 - journals.plos.org
The purpose of the current study was to clarify differences in microRNA expression
according to clinicopathological characteristics, and to investigate if miRNA profiles could …
according to clinicopathological characteristics, and to investigate if miRNA profiles could …
[HTML][HTML] Oncomirs expression profiling in uterine leiomyosarcoma cells
BC De Almeida, N Garcia, G Maffazioli… - International journal of …, 2017 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNAs that act as regulators of gene expression
at the post-transcriptional level. They play a key role in several biological processes. Their …
at the post-transcriptional level. They play a key role in several biological processes. Their …
MicroRNA in ovarian biology and disease
LK McGinnis, LJ Luense… - Cold Spring …, 2015 - perspectivesinmedicine.cshlp.org
MicroRNAs (miRNAs) are posttranscriptional gene regulatory molecules that show regulated
expression within ovarian tissue. Most research investigating miRNAs in the ovary has relied …
expression within ovarian tissue. Most research investigating miRNAs in the ovary has relied …
Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation Corrigendum in/10.3892/or. 2022.8285
X Zhou, F Zhao, ZN Wang, YX Song… - Oncology …, 2012 - spandidos-publications.com
Abstract microRNAs (miRs) are endogenous small non-coding RNAs that are aberrantly
expressed in various carcinomas. miR-152 and miR-148a have not been comprehensively …
expressed in various carcinomas. miR-152 and miR-148a have not been comprehensively …